<SEC-DOCUMENT>0001607062-20-000062-index.html : 20200316 <SEC-HEADER>0001607062-20-000062.hdr.sgml : 20200316 <ACCEPTANCE-DATETIME>20200316163023 ACCESSION NUMBER: 0001607062-20-000062 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200130 FILED AS OF DATE: 20200316 DATE AS OF CHANGE: 20200316 EFFECTIVENESS DATE: 20200316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 20717580 BUSINESS ADDRESS: STREET 1: 10102 USA TODAY WAY CITY: MIRAMAR STATE: FL ZIP: 33025 BUSINESS PHONE: 416-364-2551 MAIL ADDRESS: STREET 1: 10102 USA TODAY WAY CITY: MIRAMAR STATE: FL ZIP: 33025 </SEC-HEADER> <DOCUMENT> <TYPE>NT 10-Q <SEQUENCE>1 <FILENAME>gnbt031620formnt10q.htm <DESCRIPTION>FORM NT 10-Q <TEXT> Document 1 - file: gnbt031620formnt10q.htm
</DOCUMENT> </SEC-DOCUMENT>